
FDA Approves Foundayo, an Oral GLP-1 Pill for Weight Management
Eli Lilly's orforglipron delivered an average 12.4 percent weight loss at the highest dose in trials and can be taken without food or water restrictions.
Written by Grace MensahHealth News covers regulatory and clinical developments as they are issued: approvals, recalls, safety communications and guideline revisions. Each report names the issuing authority, describes who is affected, and states what action a reader should take. Filed quickly, and corrected openly whenever facts change.
Drug approvals, product recalls, safety advisories and revised clinical guidance, written so a reader knows immediately whether it applies to them.

Eli Lilly's orforglipron delivered an average 12.4 percent weight loss at the highest dose in trials and can be taken without food or water restrictions.
Written by Grace Mensah
The agency cleared copper histidinate injection, ending a decades-long stretch in which care for the rare copper-transport disorder was supportive only.
Written by Grace Mensah